Inactive Instrument

BROE CAPI Stock price

Equities

BCAC

US11374E1047

Dynamic Chart
Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) dropped from NASDAQ Composite Index CI
Apexigen Inc. completed the acquisition of Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others in a reverse merger transaction. CI
Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Brookline Capital Acquisition Corp. announced that it has received $0.167032 million in funding from Brookline Capital Holdings, LLC CI
Brookline Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Brookline Capital Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Blank Check Firm Brookline Capital Acquisition, Apexigen Enter Merger Agreement MT
Apexigen Inc. entered into a non-binding letter of intent to acquire Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others for approximately $210 million in a reverse merger transaction. CI
Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Certain Common Stock of Brookline Capital Acquisition Corp. are subject to a Lock-Up Agreement Ending on 27-JUL-2021. CI
Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) added to NASDAQ Composite Index CI
Brookline Capital Acquisition Corp. announced that it has received $2.47 million in funding from Brookline Capital Holdings Llc CI
Brookline Capital Acquisition Corp. has completed an IPO in the amount of $50 million. CI
More news
Brookline Capital Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any industry or sector, it intends to source, acquire and manage a business in the life sciences industry. The Company has not conducted any operations and has not generated any revenues.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock BROE CAPI - Nasdaq